BioSpace News Archive

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of senior management will present at three investor conferences in Septembe

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute on Aging (NIA) to help create a new multi-organ “human-on-a-chip” model that can realistically mimic the biology of Alzheimer’s Disease (AD) and the effects of potential new therapies under realistic human physiological conditions.

FairWarning®, leading provider of solutions that secure data in electronic health records and cloud-based applications, announced today their 100th Managed Privacy Services (MPS) customer.

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the position of Director of Analytical Development. Dr. Wung will oversee UPM’s analytical development group.

Surgeons specializing in breast cancer can now receive training in advanced oncoplastic procedures from the School of Oncoplastic Surgery (SOS).

Parker Laboratories, a worldwide leader in ultrasound products for more than 60 years, announced it has obtained the CE mark for UltraDrape™, the first combination sterile barrier and securement dressing for ultrasound-guided peripheral intravenous (UGPIV) insertions.

Oska Wellness, a technology company committed to developing consumer health and wellness products, announced today that the company will donate $10.00 for each Oska Pulse sold to the National Fibromyalgia & Chronic Pain Association during “Pain Awareness Month,” September 1 - 30. Oska’s Pain Awareness Month contribution is in partnership with FSAstore.com/HSAstore.com

Taking place in August, National ASC Month serves to promote awareness of the safe, affordable, exceptional care that ASCs provide.

Nanosphere Health Sciences, Inc. (CSE: NSHS) (OTC: NSHSF) President, COO and Co-Founder David Sutton and Chief Science Officer Dr. Richard Kaufman will both speak at the second annual Grow Up Cannabis Conference and Expo, presented by Tweed and Advanced Nutrients.

Trovagene, Inc.today announced that the European Commission (EC) has endorsed the positive opinion of the Committee for Orphan Medicinal Products (COMP) and has granted Orphan Drug Designation (ODD) for Onvansertib, a first-in-class, 3rd generation, oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the treatment of patients with Acute Myeloid Leukemia (AML).